Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood

Authors

  • Karen Bieback Ph.D.,

    Corresponding author
    1. Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service of Baden-Württemberg-Hessen, Germany; University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
    • Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service of Baden-Württemberg-Hessen, Friedrich-Ebert-Strasse 107, D-68167 Mannheim, Germany. Telephone: 49-621-3706-8216; Fax: 49-621-3706-851
    Search for more papers by this author
  • Susanne Kern,

    1. Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service of Baden-Württemberg-Hessen, Germany; University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
    Search for more papers by this author
  • Harald Klüter,

    1. Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service of Baden-Württemberg-Hessen, Germany; University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
    Search for more papers by this author
  • Hermann Eichler

    1. Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service of Baden-Württemberg-Hessen, Germany; University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
    Search for more papers by this author

Abstract

Evidence has emerged that mesenchymal stem cells (MSCs) represent a promising population for supporting new clinical concepts in cellular therapy. However, attempts to isolate MSCs from umbilical cord blood (UCB) of full-term deliveries have previously either failed or been characterized by a low yield. We investigated whether cells with MSC characteristics and multi-lineage differentiation potential can be cultivated from UCB of healthy newborns and whether yields might be maximized by optimal culture conditions or by defining UCB quality criteria.

Using optimized isolation and culture conditions, in up to 63% of 59 low-volume UCB units, cells showing a characteristic mesenchymal morphology and immune phenotype (MSC-like cells) were isolated. These were similar to control MSCs from adult bone marrow (BM). The frequency of MSC-like cells ranged from 0 to 2.3 clones per 1 × 108 mononuclear cells (MNCs). The cell clones proliferated extensively with at least 20 population doublings within eight passages. In addition, osteogenic and chondrogenic differentiation demonstrated a multi-lineage capacity comparable with BM MSCs. However, in contrast to MSCs, MSC-like cells showed a reduced sensitivity to undergo adipogenic differentiation.

Crucial points to isolate MSC-like cells from UCB were a time from collection to isolation of less than 15 hours, a net volume of more than 33 ml, and an MNC count of more than 1 × 108 MNCs.

Because MSC-like cells can be isolated at high efficacy from full-term UCB donations, we regard UCB as an additional stem cell source for experimental and potentially clinical purposes.

Ancillary